Systolic Heart Failure: Clinical Trials

3 trials for Systolic Heart Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow Systolic Heart Failure: new trials by email Literature Review of Systolic Heart Failure trials Research Report on Systolic Heart Failure

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
Iron, Saline - Systolic Heart Failure, Iron Deficiency
Phase 4CompletedUniversitätsklinikum Hamburg-Eppendorf11052017-03-072025-01-28
Platelet Inhibition in Patients With Systolic Heart Failure
Prasugrel 10 mg daily x 2 weeks, Clopidogrel 75 mg daily x 2 weeks - Systolic Heart Failure
Phase 4CompletedUniversity of Nebraska302013-05-152023-10-10
Clinical Value of Heart Rate Variability Indexes to Predict Outcomes After Exercise Training in Chronic Heart Failure
Cardiac Rehabilitation - Heart Failure, Systolic Heart Failure
Phase 4CompletedUniversidad de la Republica402010-04-012016-09-16

Narrower conditions

Heart Failure, Systolic (3)  ·  Heart Failure (2)  ·  Iron Deficiencies (1)  ·  Motor Activity (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Behavior (1)  ·  Heart Failure (1)  ·  Iron Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Cardiac Rehabilitation (1)  ·  Clopidogrel (1)  ·  Exercise (1)  ·  Iron (1)  ·  Prasugrel Hydrochloride (1)  ·  Sodium Chloride (1)

Sponsors

Universidad de la Republica (1)  ·  University of Nebraska (1)  ·  Universitätsklinikum Hamburg-Eppendorf (1)

Countries

Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Poland (1)  ·  Portugal (1)  ·  Slovenia (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Mahir Karaks, MD (1)  ·  Paul P Dobesh, PharmD (1)  ·  Roberto Ricca-Mallada, MD MSc (1)

Results publications

PMID 40159390, PMID 40300786, PMID 40740027